Primary acute dengue and the deletion in chemokine receptor 5 (CCR5D32)
MetadataShow full item record
Dengue virus is a significant arboviral pathogen that is continuing to spread due to human travel and invasion of the mosquito vectors into new regions. Chemokine receptor 5 (CCR5) has a truncated 32 base pair deletion form (CCR5Δ32), which has been associated with resistance to HIV but increased severity in some flaviviral diseases. If CCR5Δ32 is associated with dengue, European carriers of this mutation may be at increased risk. In a Western Australian population with the same frequency of CCR5Δ32 (0.08) as that found in southern Europe there was no significant difference in CCR5Δ32 allele frequency between returned travellers with and without dengue (p = 0.82, OR = 0.86, 95% CI = 0.35–2.1).
Showing items related by title, author, creator and subject.
The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerizationChakera, Aron; Seeber, R.; John, A.; Eidne, K.; Greaves, D. (2008)The Duffy antigen/receptor for chemokines (DARC) is an unusual chemokine receptor that binds a large number of inflammatory chemokines of both the CC and CXC families with nanomolar affinity, yet it lacks the ability to ...
Ex-vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-Associated sensory neuropathyMountford, Jenjira; Octaviana, F.; Estiasari, R.; Setiawan, D.; Ariyanto, I.; Lee, Silvia; Gaff, Jessica; Chew, C.; Jackaman, Connie; Kamerman, Peter; Cherry, C.; Price, Patricia (2018)Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. Objective: HIV-Associated sensory neuropathy (HIV-SN) remains common in HIV+ individuals receiving antiretroviral therapy (ART), even though neurotoxic ...
Chemokine receptor expression on dendritic cells is normal in HIV-infected patients with a stable response to ART, but chemokine levels remain elevatedLee, S.; Fernandez, S.; French, M.; Price, Patricia (2011)The development of strategies to optimize T-cell responses in previously immunodeficient HIV patients with a stable virological response to ART requires an understanding of the factors that affect responsiveness. Chemokines ...